Search for: "Mylan Laboratories Ltd."
Results 81 - 100
of 116
Sort by Relevance
|
Sort by Date
18 Dec 2009, 9:59 am
Mylan Pharmaceuticals Inc., Mylan, Inc., Matrix Laboratories Ltd. and Matrix Laboratories Inc. [read post]
16 Dec 2009, 3:39 am
Reddy's Laboratories Ltd. et al. [read post]
9 Dec 2009, 3:59 pm
Ltd. et al. v. [read post]
1 Dec 2009, 9:45 am
Mylan Inc., Matrix Laboratories Limited and Matrix Laboratories, Inc. [read post]
25 Nov 2009, 12:00 pm
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Ecuador to define its compulsory licence legislation (IP Watch) (Patently-O) Tavanic (Levofloxacin) – UK: Supreme Court refuses permission to appeal in Generics (UK) Ltd v Daiichi Pharmaceuticals (The SPC Blog) (JIPLP) General Nil: The value of patents in a major crisis such as an influenza pandemic –… [read post]
27 Sep 2009, 5:13 pm
Takeda Chemical Industries, Ltd., et al. ; Alphapharm Pty., Ltd., et al. v. [read post]
9 Sep 2009, 7:14 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: CAFC debates whether claim term ‘animal’ includes humans: Martek Biosciences Corp v Nutrinova, Inc (Gray on Claims) (Patently-O) (Patently-O) (IP Watchdog) General USPTO-Pfizer workshop on IP & innovation in Mumbai (Intellectual Property Watch) Australia: Full Federal Court unanimously confirms that… [read post]
28 Aug 2009, 8:11 am
Mylan Pharmaceuticals Inc., Matrix Laboratories Ltd. and Matrix Laboratories Inc. [read post]
21 Apr 2009, 2:34 am
On March 31, 2009, Caraco Pharmaceutical Laboratories, Ltd. announced a nationwide recall of all lots of its digoxin tablets due to potential manufacturing defects.The recall notice indicates that Caraco’s digoxin pills may have been manufactured at a size larger than intended, with the result being that the pills may contain an excessive dose of the active ingredient of the medication. [read post]
17 Apr 2009, 12:00 am
Ltd. sues 11 generics companies over Levaquin patents (Law 360) Lexapro (Escitalopram) – Netherlands District court invalidates Lundbeck’s patent EP ‘066 (IPKat) Lexapro (Escitalopram) - Baldwin’s rules explained (The SPC Blog) Lexapro (Escitalopram) – federal district Judge agrees to determine whether Forest Laboratories destroyed key documents (Law 360) Pegasys (PEG interferon alfa 2a) – Roche wins post grant opposition… [read post]
31 Mar 2009, 12:16 pm
Digitek Brand Of Generic Digoxin Tablets Had Been Recalled In April 2008 For Same Reason (Posted by Tom Lamb at DrugInjuryWatch.com) On March 31, 2009 the FDA announced another generic digoxin pill recall by posting this company press release on the agency's web site: "Caraco Pharmaceutical Laboratories, Ltd. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
17 Dec 2008, 5:54 am
The challenges to the '777 patent had been initiated by Defendants-Appellants Mylan Laboratories, Inc., Mylan Pharmaceuticals, Inc., and UDL Laboratories, Inc. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation (IP Law Observer) Lescol (Fluvastatin) - US: Mylan confirms first-to-file patent challenge to Lescol by Novartis (SmartBrief) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd… [read post]
19 Sep 2008, 6:00 pm
: (Spicy IP), India: Supreme Court on exclusive marketing rights: (Spicy IP), Japan: First induced pluripotent stem (iPS) cell patent at Kyoto University: (Competitive Info), Slovenia: Supplementary protection certificates in Slovenia: (The SPC Blog), United States: Biotech/pharma lobbying scoreboard – second quarter update – part II: (Patent Docs), United States: Ferring Pharmaceuticals argues to bring down direct purchaser suits: (Law 360), United States: Transferred… [read post]
2 Aug 2008, 12:54 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
28 Jul 2008, 7:01 pm
Mylan Laboratories, Inc., 520 F.3d 1358, 1364 (Fed. [read post]
25 Jul 2008, 2:11 am
Mylan Laboratories, Inc., 520 F.3d 1358, 1364 (Fed. [read post]
16 Jul 2008, 1:55 am
In 2005 and 2007, Abbott filed similar infringement lawsuits against Mylan, Impax Laboratories, Teva and Wockhardt Ltd. but earlier this year entered into agreement with Mylan to allow launching a generic version no later than January 1, 2009. [read post]
